Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis

Sulfasalazine has long been used for the treatment of rheumatoid arthritis and is often chosen as a first-line treatment. Here, we report a case of sulfasalazine-induced autoimmune thrombocytopenia and review the mechanisms behind drug-induced immune thrombocytopenia (DITP) and the approach to its d...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayan, Nehal, Rigby, Shirley, Carlucci, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Case Based Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290041/
https://www.ncbi.nlm.nih.gov/pubmed/27778097
http://dx.doi.org/10.1007/s10067-016-3420-9
_version_ 1782504581852299264
author Narayan, Nehal
Rigby, Shirley
Carlucci, Francesco
author_facet Narayan, Nehal
Rigby, Shirley
Carlucci, Francesco
author_sort Narayan, Nehal
collection PubMed
description Sulfasalazine has long been used for the treatment of rheumatoid arthritis and is often chosen as a first-line treatment. Here, we report a case of sulfasalazine-induced autoimmune thrombocytopenia and review the mechanisms behind drug-induced immune thrombocytopenia (DITP) and the approach to its diagnosis and management.
format Online
Article
Text
id pubmed-5290041
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-52900412017-02-16 Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis Narayan, Nehal Rigby, Shirley Carlucci, Francesco Clin Rheumatol Case Based Review Sulfasalazine has long been used for the treatment of rheumatoid arthritis and is often chosen as a first-line treatment. Here, we report a case of sulfasalazine-induced autoimmune thrombocytopenia and review the mechanisms behind drug-induced immune thrombocytopenia (DITP) and the approach to its diagnosis and management. Springer London 2016-10-24 2017 /pmc/articles/PMC5290041/ /pubmed/27778097 http://dx.doi.org/10.1007/s10067-016-3420-9 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Based Review
Narayan, Nehal
Rigby, Shirley
Carlucci, Francesco
Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title_full Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title_fullStr Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title_full_unstemmed Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title_short Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
title_sort sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
topic Case Based Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290041/
https://www.ncbi.nlm.nih.gov/pubmed/27778097
http://dx.doi.org/10.1007/s10067-016-3420-9
work_keys_str_mv AT narayannehal sulfasalazineinducedimmunethrombocytopeniainapatientwithrheumatoidarthritis
AT rigbyshirley sulfasalazineinducedimmunethrombocytopeniainapatientwithrheumatoidarthritis
AT carluccifrancesco sulfasalazineinducedimmunethrombocytopeniainapatientwithrheumatoidarthritis

Ejemplares similares